Larimar Therapeutics, Inc. · NASDAQ:LRMR
Opaleye Management Inc. reported a 6.17% stake in Larimar Therapeutics, Inc. (Schedule 13G)
Event Apr 9, 2025 · Filed Apr 16, 2025
Opaleye Management Inc. reported a 6.17% stake in Larimar Therapeutics, Inc., 3,952,409 shares, as a passive investor on Apr 9, 2025. Filed Apr 16, 2025 (Schedule 13G).
- Stake
- 6.17%
- Shares
- 3,952,409
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Opaleye Management, Inc. | 6.17% | 3,952,409 |
| Opaleye, L.P. | 6.17% | 3,952,409 |
| James Silverman | 6.17% | 3,952,409 |
Source
Related
- Larimar Therapeutics, Inc.
- Opaleye Management Inc.
- Larimar Therapeutics, Inc. shareholders
- Schedule 13G · Opaleye Management Inc. · Aug 29, 2025
- Form 4 · Harlow John B. Jr. · Oct 1, 2026
- Form 4 · Hamilton Thomas Edward · Jul 8, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 2, 2026